Drug Researchers Refuse To Follow The Law. The Government Isn’t Stopping Them

Podcast

Broadcast on: January 24, 2020

Podcast: Science Friday

Before any new drug comes to market, it goes through a time-consuming process. Researchers have to recruit human subjects for a clinical trial, collect all the data, and analyze the results. All of that can take years to complete, but the end result could be worth it: a drug that treats a rare disease or improves patients lives with fewer side effects.

SciFri · Drug Researchers Refuse To Follow The Law. The Government Is Not Stopping Them.

Financial Times awards MRCT Center Faculty Co-Director, Mark Barnes, “2019 Legal Innovator of the Year”

December 10, 2019, New York, NY

At the prestigious December 9 Financial Times “Innovative Lawyers” awards, an annual contest that honors elite law firms, companies and legal service providers, Mark Barnes, JD LLM Multi-Regional Clinical Trials Center Faculty Co-Director and health care partner at Ropes & Gray, was honored with the “Legal Innovator of the Year” award, given to one exceptional lawyer.

Mark received the “Legal Innovator of the Year” award for his leadership in health care and life sciences, including his role in co-founding Vivli, a platform to help the scientific community benefit from the sharing of clinical trial data. The MRCT Center launched the non-profit Vivli in 2018 to advance innovation and discovery through data sharing while protecting personal information. In noting the FT judges’ praise for the originality of Mark’s work, the publication wrote, “At a time of heightened public concern over the sharing of personal data, not to mention questions over the value for money provided by either lawyers or U.S. healthcare institutions, Mark Barnes stands out as a true innovator.”

Find out more about Mark’s work at the MRCT Center.

© Marie-Helene Carleton / FT

Read Article >